CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Current Management of Gram-Negative Septic Shock

Published: Mon, 19 Nov 2018 12:00:00 EST
Septic shock is a potentially life-threatening condition, and its management can be challenging. How are Gram-negative infections best treated?
Current Opinion in Infectious Diseases

The Impact of Technology on Surgery: The Future Is Unwritten

Published: Mon, 19 Nov 2018 12:00:00 EST
In what ways might technological advances impact the field of surgery?
Annals of Surgery

Migraine in America Symptoms and Treatment (MAST) Study

Published: Mon, 19 Nov 2018 12:00:00 EST
This article summarizes both the design and the findings of the MAST study, an epidemiologic survey of people with migraine in the United States.
Headache
Displaying results 13-15 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

SVB buys Leerink for $280M, boosting its life sciences business

Published: Wed, 14 Nov 2018 13:09:45 +0000
Silicon Valley Bank parent SVB is buying Leerink to create a new company with a "complete capital markets offering."

United Neuroscience’s ‘endobody’ Parkinson’s vaccine shows promise in early tests

Published: Wed, 14 Nov 2018 10:08:17 +0000
United Neuroscience is developing a novel class of vaccines that target aberrant proteins implicated in some neurodegenerative diseases. Now it has strong preclinical evidence showing that its anti-alpha-synuclein vaccine could hold promise in Parkinson’s disease.

Preclinical biotech Synthorx wants a $100M IPO

Published: Wed, 14 Nov 2018 09:47:41 +0000
Moderna will be getting all the headlines for its monster $500 million IPO attempt this week, but that shouldn’t overshadow the major $100 million IPO that early-stage Synthorx has just announced, and what this says about the biotech market.
Displaying results 13-15 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top